Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The receptor binding domain of the diphtheria toxin, located within Fragment B (residues ~194-535), is responsible for specifically recognizing and binding to heparin-binding EGF-like growth factor precursor (HB-EGF) on the surface of human cells. This interaction is essential for the toxin's entry into the cell and subsequent cytotoxicity.
Binds to HB-EGF, facilitating endocytosis and toxin entry into cells
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Corynebacterium diphtheriae Toxin Receptor Binding Domain.